Barrow, Hanley, Mewhinney & Strauss’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
SBH
RA
Barrow, Hanley, Mewhinney & Strauss's NGVT Position: Q2 2026 in Review
Barrow, Hanley, Mewhinney & Strauss increased its Ingevity (NGVT) stake by 8.9% in Q2 2026, buying an estimated $288 and bringing the position to 49 shares worth $3.66K. The position accounts for ﹤0.01% of the portfolio, ranked #315.
Barrow, Hanley, Mewhinney & Strauss first reported a position in NGVT in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.28M in Q2 2020. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss held 49 shares of Ingevity worth $3.66K as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss bought 4 Ingevity shares in Q2 2026, an estimated $288.
- Ingevity made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #315 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Ingevity in Q4 2019 and has held it in 20 quarters since.
- Barrow, Hanley, Mewhinney & Strauss's Ingevity position peaked at $1.28M in Q2 2020.
- 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.